Our Vision:
We envision a future where every annual wellness visit can include a simple blood test for early cancer screening, helping veterinarians act sooner and giving dogs more time.
Our Science: Cancer diagnostic based on biology, genomics, and AI.
Cancer is a biological process that can leave molecular traces in the bloodstream.
When cells die, they release cell-free DNA (cfDNA) into circulation. These DNA fragments can carry information about their cellular origin and the biological processes occurring in the body.
Our approach is to analyse these signals at multiple levels and combine them using computational methods and AI.
Our Team
Different backgrounds, one mission
giving dogs more time.
Shahab Matin
Founder & CEO
Dr Sven Sewitz
Co-Founder & CSO
Gayathri Srinivasan
Workstudent- Bioinformatics
Dr Stefan Budach
Product Management
Anh (Hang Mai) V.
Workstudent - Bioinformatics
Adriano Pitoni
Business Development Specialist
Aindrila Majumdar
Marketing Intern
Our Partners & Investors
Fraunhofer HHI
Technology Partner · Trustworthy & Explainable AI
testblu is part of the Fraunhofer HHI Silicon Allee Venture Lab, supported by the Fraunhofer-Gesellschaft.
Together with Fraunhofer HHI, we are developing the Explainable AI (XAI) layer of CaniSense, making complex genomic and fragmentomic predictions more transparent and interpretable.
Silicon Allee
Venture & Technology Ecosystem Partner
Silicon Allee connects testblu with Berlin's technology and deep-tech ecosystem, supporting our journey from scientific innovation to a scalable healthcare technology.
Through the Silicon Allee Venture Lab at Fraunhofer HHI, we are building CaniSense at the intersection of AI, biotechnology and veterinary diagnostics.
KU Leuven
Research Partner & Investor · Liquid Biopsy & Fragmentomics
We collaborate with KU Leuven on the scientific development of CaniSense, focusing on cfDNA fragmentomics and liquid biopsy.